Prognostic Value of the P16/P53 Immunohistochemical Association in Oropharyngeal Squamous Cell Carcinomas
Journal of Otolaryngology - Head & Neck Surgery · 2026-07 · 55
DOI: 10.1177/19160216261451818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Otolaryngology - Head & Neck Surgery, online erschienen am 04.08.2026. Verfasst von Antoine Lagadec und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Oto-Rhino-Laryngologie et Chirurgie Cervico-Faciale, Hôpital La Croix Rousse, Hospices Civils de Lyon, France. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Tumor Suppressor Protein p53, Carcinoma, Squamous Cell, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Importance: Accurate HPV status diagnosis is essential for managing oropharyngeal squamous cell carcinoma.
Objective
We aimed to refine HPV status determination using a cost-effective and reliable approach by integrating the p53 immunohistochemical marker with the conventional p16 marker. We assessed the association between HPV status and the p16/p53 tumor immunohistochemical status and analyzed patient survival based on p16/p53 expression. Design, Setting, Participants, and Exposures: This retrospective, single-center study included 285 patients with oropharyngeal squamous cell carcinoma (2017-2022) with known p16/p53 immunohistochemical profiles. In a subset of 92 patients, HPV status was formally determined using polymerase chain reaction or in situ hybridization. Outcome Measures and Results: The p16/p53 test was an excellent predictor of HPV status (specificity: 100%, sensitivity: 98.48%), significantly outperforming p16 alone ( P < .01). Patients with a p16+/p53WT profile had superior 5-year overall survival (82.2%; 108/131) and recurrence-free survival (79.4%; 104/131). Patients with discordant profiles (p16+/p53MT, p16−/p53WT) had survival outcomes similar to HPV-independent oropharyngeal squamous cell carcinomas.
Conclusion
The p16/p53 immunohistochemical profile appears to be a reliable surrogate marker for HPV status and a strong predictor of survival. It could help identify discordant cases, helping prevent inappropriate therapeutic de-escalation. Relevance: With the advancement of artificial intelligence, integrating additional markers into an algorithmic analysis could further refine patient classification and enable more personalized therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Oto-Rhino-Laryngologie et Chirurgie Cervico-Faciale, Hôpital La Croix Rousse, Hospices Civils de Lyon, France.
- Department of Pathology, Institut de Pathologie Multisite, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
- Faculté de Médecine, Université Lyon 1, France.
- Service de Radiothérapie, Groupement Hospitalier Sud, Hospices Civil de Lyon, Pierre-Bénite, France.
- Service d'Oncologie, Hôpital La Croix Rousse, Hospices Civils de Lyon, France.
ORCID-Profile: Antoine Lagadec
Zitieren
APA
Lagadec, A., Benzerdjeb, N., Lapierre, A., Alsugair, Z., Bruyas, A., Blanc, J., Céruse, P., & Philouze, P. (2026). Prognostic Value of the P16/P53 Immunohistochemical Association in Oropharyngeal Squamous Cell Carcinomas. Journal of Otolaryngology - Head & Neck Surgery, 55. https://doi.org/10.1177/19160216261451818
Vancouver
Lagadec A, Benzerdjeb N, Lapierre A, Alsugair Z, Bruyas A, Blanc J, et al. Prognostic Value of the P16/P53 Immunohistochemical Association in Oropharyngeal Squamous Cell Carcinomas. Journal of Otolaryngology - Head & Neck Surgery. 2026;55. doi:10.1177/19160216261451818
BibTeX
@article{Lagadec2026,
author = {Lagadec, Antoine and Benzerdjeb, Nazim and Lapierre, Ariane and Alsugair, Ziyad and Bruyas, Amandine and Blanc, Jacques and Céruse, Philippe and Philouze, Pierre},
title = {Prognostic Value of the P16/P53 Immunohistochemical Association in Oropharyngeal Squamous Cell Carcinomas},
journal = {Journal of Otolaryngology - Head & Neck Surgery},
year = {2026},
volume = {55},
doi = {10.1177/19160216261451818}
}
EUVIMED